Woodside Acquisitions Inc. 2022-05-18 Health critical FDA
Health · FDA · Recall #FDA-Z-1045-2022
Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold); COVID 19 Test Recall
Issued May 18, 2022 · Woodside Acquisitions Inc.
In May 2022, Woodside Acquisitions Inc. recalled the Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold); COVID 19 Test, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Firm distributed tests which have not been cleared or authorized for marketing or distribution in the United States.
What you should do
- 1 Stop using Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold); COVID 19 Test right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Woodside Acquisitions Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Woodside Acquisitions Inc.
- Category
- Health
- Recall date
- May 18, 2022
- Units affected
- Not reported
- Sold at
- US distributions to states of: AL and GA.
- Recall number
- FDA-Z-1045-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Woodside Acquisitions Inc. has 1 recall in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.